持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2015/11/24 | 7,700 | 7,730 | 7,670 | 7,700 | ±0 | ±0% | 31,900 |
2015/11/20 | 7,580 | 7,700 | 7,520 | 7,700 | +180 | +2.4% | 48,300 |
2015/11/19 | 7,590 | 7,660 | 7,510 | 7,520 | +30 | +0.4% | 44,300 |
2015/11/18 | 7,520 | 7,600 | 7,480 | 7,490 | +20 | +0.3% | 29,200 |
2015/11/17 | 7,490 | 7,530 | 7,420 | 7,470 | +90 | +1.2% | 33,600 |
2015/11/16 | 7,310 | 7,420 | 7,220 | 7,380 | ±0 | ±0% | 22,300 |
2015/11/13 | 7,370 | 7,400 | 7,310 | 7,380 | -30 | -0.4% | 21,300 |
2015/11/12 | 7,480 | 7,480 | 7,380 | 7,410 | -50 | -0.7% | 41,700 |
2015/11/11 | 7,460 | 7,520 | 7,410 | 7,460 | ±0 | ±0% | 27,000 |
2015/11/10 | 7,350 | 7,470 | 7,350 | 7,460 | +20 | +0.3% | 41,300 |
2015/11/09 | 7,450 | 7,530 | 7,400 | 7,440 | +20 | +0.3% | 32,900 |
2015/11/06 | 7,300 | 7,430 | 7,300 | 7,420 | +130 | +1.8% | 24,500 |
2015/11/05 | 7,230 | 7,340 | 7,200 | 7,290 | +70 | +1% | 19,500 |
2015/11/04 | 7,160 | 7,350 | 7,160 | 7,220 | +170 | +2.4% | 41,900 |
2015/11/02 | 7,250 | 7,250 | 6,990 | 7,050 | -120 | -1.7% | 38,200 |
2015/10/30 | 7,110 | 7,250 | 7,100 | 7,170 | +190 | +2.7% | 38,900 |
2015/10/29 | 6,960 | 7,070 | 6,920 | 6,980 | +40 | +0.6% | 50,600 |
2015/10/28 | 7,000 | 7,100 | 6,920 | 6,940 | -80 | -1.1% | 32,200 |
2015/10/27 | 7,130 | 7,130 | 6,990 | 7,020 | -120 | -1.7% | 40,400 |
2015/10/26 | 7,160 | 7,190 | 7,100 | 7,140 | +60 | +0.8% | 19,300 |
2015/10/23 | 7,100 | 7,310 | 7,070 | 7,080 | +150 | +2.2% | 37,600 |
2015/10/22 | 7,010 | 7,090 | 6,920 | 6,930 | -120 | -1.7% | 13,600 |
2015/10/21 | 6,900 | 7,060 | 6,850 | 7,050 | +170 | +2.5% | 29,700 |
2015/10/20 | 6,980 | 7,060 | 6,820 | 6,880 | -100 | -1.4% | 50,300 |
2015/10/19 | 7,000 | 7,080 | 6,920 | 6,980 | -40 | -0.6% | 17,200 |
2015/10/16 | 7,030 | 7,140 | 7,010 | 7,020 | ±0 | ±0% | 14,500 |
2015/10/15 | 6,800 | 7,040 | 6,800 | 7,020 | +200 | +2.9% | 25,100 |
2015/10/14 | 6,850 | 6,910 | 6,760 | 6,820 | -70 | -1% | 27,400 |
2015/10/13 | 6,900 | 7,060 | 6,890 | 6,890 | -110 | -1.6% | 30,400 |
2015/10/09 | 6,870 | 7,010 | 6,850 | 7,000 | +230 | +3.4% | 36,900 |
2015/10/08 | 6,970 | 6,970 | 6,770 | 6,770 | -200 | -2.9% | 20,300 |
2015/10/07 | 7,050 | 7,050 | 6,910 | 6,970 | -80 | -1.1% | 23,100 |
2015/10/06 | 7,090 | 7,120 | 7,030 | 7,050 | +20 | +0.3% | 20,600 |
2015/10/05 | 6,970 | 7,090 | 6,920 | 7,030 | +140 | +2% | 20,000 |
2015/10/02 | 7,020 | 7,030 | 6,840 | 6,890 | -130 | -1.9% | 22,600 |
2015/10/01 | 6,980 | 7,070 | 6,860 | 7,020 | +110 | +1.6% | 37,100 |
2015/09/30 | 6,850 | 7,000 | 6,800 | 6,910 | +140 | +2.1% | 48,300 |
2015/09/29 | 6,980 | 6,990 | 6,720 | 6,770 | -400 | -5.6% | 44,000 |
2015/09/28 | 7,250 | 7,250 | 7,080 | 7,170 | -70 | -1% | 31,600 |
2015/09/25 | 7,170 | 7,260 | 7,040 | 7,240 | +70 | +1% | 38,800 |
2015/09/24 | 7,260 | 7,390 | 7,170 | 7,170 | -220 | -3% | 36,600 |
2015/09/18 | 7,480 | 7,520 | 7,370 | 7,390 | -70 | -0.9% | 30,100 |
2015/09/17 | 7,520 | 7,520 | 7,400 | 7,460 | -10 | -0.1% | 24,500 |
2015/09/16 | 7,510 | 7,510 | 7,370 | 7,470 | +10 | +0.1% | 15,300 |
2015/09/15 | 7,380 | 7,520 | 7,330 | 7,460 | +140 | +1.9% | 23,500 |
2015/09/14 | 7,550 | 7,550 | 7,320 | 7,320 | -230 | -3% | 43,000 |
2015/09/11 | 7,360 | 7,610 | 7,280 | 7,550 | +40 | +0.5% | 50,800 |
2015/09/10 | 7,530 | 7,550 | 7,330 | 7,510 | -170 | -2.2% | 28,000 |
2015/09/09 | 7,470 | 7,680 | 7,410 | 7,680 | +440 | +6.1% | 33,700 |
2015/09/08 | 7,540 | 7,540 | 7,230 | 7,240 | -280 | -3.7% | 30,200 |
2201~
2250
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム